IJLSSR, VOLUME 3, ISSUE 3, MAY 2017:986-991

Research Article (Open access)

Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear
Screening in Remote Area of Bagalkot- A Camp Approach

Syed Sarfaraz Ali1*, Prabhu MH2, Saroj Deoghare3, S.S. Inamdar4, Deepak N5
1Post Graduate Student, Department of Pathology, S.N.M.C. & H.S.K. Hospital, Bagalkot, India
2Associate Professor, Department of Pathology, S.N.M.C. & H.S.K. Hospital, Bagalkot, India
3Post Graduate Student, Department of Pathology, S.N.M.C. & H.S.K. Hospital, Bagalkot, India
4HOD, Department of Pathology, S.N.M.C. & H.S.K. Hospital, Bagalkot, India
5Assistant Professor, Department of Pathology, S.N.M.C. & H.S.K. Hospital, Bagalkot, India

*Address for Correspondence: Dr. Syed Sarfaraz Ali, Post Graduate Student, Department of Pathology,
S. Nijalingappa Medical College, Navanagar, Bagalkot, Karnataka, India

Received: 20 February 2017/Revised: 22 March 2017/Accepted: 17 April 2017

ABSTRACT-Background: Cervical screening through conventional cervical cytology is most commonly used throughout the world. The Cervical cancer is the second most common cancer worldwide and in developing countries, the leading cause of death. It is one of the most preventable and curable of all cancers.
Objective: To Study the role of Pap smear in detecting neoplastic and non-neoplastic lesions of cervix and to determine the occurrence of various lesions in remote area of Bagalkot.
Methods: This is prospective study of 240 women with age group 20 to 60 years was carried out from May 2015 to June 2016 cytology section of pathology department, S. Nijalingappa Medical College & H.S.K Hospital & Research Centre, Bagalkot, India. Pap smears were prepared, fixed, stained and carefully examined.
Results: In this study, Reactive cellular changes associated with inflammation was the most common with 182 cases (75.8%) followed by Low-grade squamous intraepithelial lesions (SIL) with 11 cases (4.5%), then atypical squamous epithelial cells of undetermined significance 8 cases (3.3%), High-grade squamous intraepithelial lesions with 5 cases (2.1%), Atrophy with 3 cases (1.3%) and Atypical Glandular Cell in 3 cases (1.3%). The average age of women for all the epithelial abnormalities was 40 years.
Conclusion: This study will increase awareness of the Pap test and cervical cancer, thereby paving a way for the prevention of cervical cancer.
Key words:- Pap smear, Cervical cancer, The Bethesda System, Squamous intraepithelial lesions (SIL)

INTRODUCTION
The Papanicolaou (Pap) smear was introduced in 1941 and became the standard screening test for cervical cancer and premalignant lesions.[1] In India, cervical cancer is the most common woman-related cancer, killing 1 woman every 8 minutes. About 5,30,232 women are affected by cervical cancer in the world and about 275,008 succumb to this disease.[2-3] According to the National Cancer Registry Program by Indian Council of Medical Research (ICMR) in the year 2007, about 1,32,082 are affected by cancer of the cervix every year in India and 74,118 die of the disease According to a recent study the burden of cancer of the cervix is increasing in India. There were 96,156 cases detected in the year 2011 and the estimated number of cases for the year 2026 is expected to be 1,48,813.[4]
The Papanicolaou cervical cytology test is capable of detecting cervical cancer at an early stage and is used widely in developed countries, where it has decreased both the incidence and mortality of cervical cancer.[5-6] It has been estimated that the use of simple and cost-effective technique has reduced the incidence of cervical cancer by at least 70%. Even today, many developing countries lack the facility to carry out wide-spread Pap screening.[7]
Many studies report that exposure to human papilloma virus (HPV), active sexual life, multiparity, hormonal contraception, genetic factors and smoking may con-tribute to the initiation of cervical cancer.[8-10]
Histopathological examination is the gold standard. This correlation is also useful for continuous quality improvement, which is a must for many cytology laboratories, in particular, those laboratories that apply the Bethesda system in their diagnosis.[11-12]
Aim of study is to determine the clinico-pathological importance of conventional Pap smear in detecting premalignant & malignant lesion of cervix and to explore the prevalence of various epithelial cell abnormalities in remote area of Bagalkot.

MATERIALS AND METHODS
The present study is prospective study and carried out in the duration of May 2015 to June 2016. Total 240 women with age ranges from 20 - 60 yrs who attended Camp organized every month at Kaladgi funded by SNMC and HSK hospital, India. In this study we have conducted Pap test in female who voluntarily consented to undergo this test. During the period May 2015 to June 2016 all female came for Pap smear test were included in the study irrespective of presence of co-morbid medical illnesses like diabetes mellitus, hypertension, thyroid disease, renal conditions, etc. Those who presented with excessive white discharge per vaginum, bleeding per vaginum, irregular menstruation, pelvic pain and dysparerunia were considered as symptomatic. Pregnant women and hysterectomy women were excluded from study. Before taking the Pap smear we ensured that the patient was not menstruating.

Procedure of sampling: All the symptomatic patients’ undergone cervical examination and samples were taken from Squamo-columnar junction & Endocervix by Ayre’s spatula & Cytobrush respectively. The smears prepared & fixed in 95% ethyl alcohol. In the laboratory the Pap staining was done and smears were evaluated by light microscopy using the 2014 Bethesda System for reporting cervical cytological diagnoses. The epithelial cell abnormalities particularly the squamous epithelial abnormality has been categorized into atypical squamous cells (ASC) including ASC of undetermined significance (ASC-US) and ASC cannot exclude high grade squamous intraepithelial lesions (ASC-H) and squamous intraepithelial lesion (SIL). SIL was again subdivided into low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL). Frank invasive malignancy was termed as squamous cell carcinoma. Similarly, glandular cell abnormalities were categorized into atypical endocervical cells not otherwise specified atypical endometrial cell not otherwise specified and atypical glandular cell not otherwise specified. Suspected cases were counseled and were advised to undergo colposcopic examination and biopsy for histopathological examination.

RESULTS
A total of 240 cases were analyzed for above men-tioned period. The age of women who was attended camp range from 40 to 60 years with an average age of 50 years. The most of the women who were attended were in age group of 30 - 39 years (Table 1).

Table 1: Age- wise distribution of total number of patients

Age (in years) No. of cases Percentage (%)
20-29 79 32.9
30-39 110 45.8
40-49 46 19.2
50 or > 5 02.1
Total 240 100


The chief complats of the women attending camp was Vaginal discharge followed by pain in abdomen, intermenstrual bleeding, post coital bleeding and others (Fig 1).



Fig 1 : Chief complats of the women attending camp


Twelve (5%) smears were found to be unsatisfactory for evaluation. Thirteen (5.4%) were normal. The neg-ative for intraepithelial lesion category has the following findings: reactive cellular changes associated with inflammation 182 cases (75.8%) and Atrophic changes 3 cases (1.3%). In Epithelial Cell Abnormalities: ASCUS/ASC-H was 12 cases (5%), LSIL 11 cases (4.6%), HSIL 5 cases (2.1%) and AGCUS 2 cases (0.8%). [Fig: 2, 3, 4 & 5]
All Premalignant and malignant lesions had mentioned in Table 2 and their age-wise distributions were men-tioned in Table 3. The average age of women for all the epithelial abnormalities was 40 years.

Table 2: Finding of Pap smear cytology

S No.DiagnosisNo. %
1Unsatisfactory for evaluation (UE)1205.0%
2 Normal 13 05.4%
3 Reactive cellular changes associated with inflammation/Atrophy (RCCI/A) 185 77.1%
4 ASCUS/ASC–H 12 05.0%
5 Low-grade Squamous Intraepithelial Lesion(LSIL) 11 04.6%
6 High-grade Squamous Intraepithelial Lesion(HSIL) 05 02.1%
7 Squamous cell carcinoma (SCC) 00 00.0%
8 AGCUS 02 00.8%
9 AGCUS probably neoplastic origin 00 00.0%
10 Adenocarcinoma 00 00.0%
11 Others: Granulosa cell tumor 00 00.0%
Clear cell carcinoma 00 00.0%
Total 240100%


Table 3: Age- wise, finding of Pap smear cytology

Age Unsatisfactory Normal Inflammatory Atrophy ASCUS ASC-H LSIL HSIL AGC No. of cases (%)
20-29 4 5 67 - 2 - 1 - - 79 (32.9%)
30-39 6 6 86 - 5 1 4 2 1 110 (45.8%)
40-49 2 2 28 1 2 2 6 1 1 46 (19.2%)
50 or > - - 1 2 - - - 2 - 5(02.1%)
Total 12 13 182 3 9 3 11 5 2 240(100%)


The cases which were diagnosed on smear as Epithelial Cell Abnormalities were followed and colposcopy biopsy was done and the final histopathology diagnosis were done as depicted in Table 4.

Table 4: Colposcopy Biopsy for conformation

PAP report No. case Biopsy Not willing Histopathology Diagnosis
ASCUS 9 7 2 ChronicNon–Specific Cervicitis (7 cases)
ASC - H 3 3 - Severe Dysplasia (2 cases)
Mod. differentiated focal keratinizing SCC (1 case)
LSIL 11 6 5 Mild dysplasia CIN I (6 cases)
HSIL 5 4 1 Severe dysplasia CIN III (3 cases)
Squamous Cell Carcinoma (1 case)




Fig. 2: Inflammatory smear Smear shows Superfecial &
intermediate cells with inflammatory cells dispersed in background




Fig. 3: Atypical Squamous cells of undeterminate significance
(ASCUS) shows increase nucleus size with minimal hyperchromasia & nuclear irregularity




Fig. 4: Low grade squamous intraepithelial lesion (LSIL): Smear
shows increase innuclear size with variable hyperchromasia and slightly irregular nuclear membrane




Fig. 5: High grade squamous intraepithelial lesion (HSIL): smear
shows variation and cell size with hyperchromatic nucleaus and increased nucleocytoplasmic ratio


DISCUSSION
The Papanicolaou (Pap) test is a screening test per-formed using cells from the uterine cervix. The test is simple, quick and painless. By cervical screening incidence and prevalence of cervical cancer and related mortality and morbidity can be reduced.[7]
The incidence of cervical cancer has been reduced to more than 50% in developed countries in past 30 yrs because of wide spread screening where as in develop-ing countries there is high burden especially in under-served population due to lack of screening and health care infrastructure.[13] The results of present study and their correlation with other workers are discussed below in following Table 5 and 6.

Table 5: Comparison of age wise distribution with other studies

Age Pragya Sharma etal. (2010) [14] Delhi Chankapa YD et al (2011)[15] Sikkim Bhavika K. V et al (2014) [13] Gujarat Malay Bajpai (2016) [16] UP Present study Kaladgi
20 – 29 190 293 67 111 79
30 – 39 24 327 167 103 110
40 – 49 - 241 140 46
50 – 59 - 107 60 42 5
60 or > - - 6644
Total 214 968 500 300 240


Table 6: Comparison of findings of Pap smear cytology with other studies

Name of worker No. cases Unsatisfactory (%) Normal (%) Atrophic changes (%) Inflammatory Lesion (%) SIL (%)
Pragya Sharma et al. (2010) 214 5.6 15.9 7.9 64.5 6.07
Chankapa YD et al (2011) 968 - 95.15 - 4.02 0.9
Bhavika K. Vaghela et al (2014) 400 13.25 1.50 3 53 20.5
Malay Bajpai (2016) 300 11.33 33.33 9 41.66 4.40
Present study 240 5 5.4 1.25 75.83 11.7


Above table shows that higher incidence of inflammatory smears in present study with lower incidence of diag-nosed as normal smears. Incidence of atrophic changes was lower in present study compare to other study. Incidence of inflammatory lesions and SIL were similar to other studies.

Table 7: Age wise distribution of Squamous Intraepithelial Lesion (SIL)

Age Pragya Sharma et al. % (No) [14] Chankapa YD et al. % (No.) [15] Bhavika KV et al. % (No.) [13] Malay Bajpai et al. % (No.) [16] Present study % (No.)
20 – 29 5.34(190) 0.21 (293) 1.9 (67) 0.33 (111) 1.25 (79)
30 – 39 0.73 (24) 0.41 (327) 4.7 (167) 2.67 (103) 5 (110)
40 – 49- 0.1 (241) 6.7 (140) 4.58 (46)
50 – 59 - 0.2 (107) 3 (60) 0.7 (42) 0.83 (5)
60 or > - - 4.2 (66) 0.7 (44)
Total 6.07 (214) 0.9 (968) 20.5 (500) 4.40 (300) 11.7 (240)


The incidence of SIL is found to be similar to other studies. In present and other studies shows the abnormal epithelial lesions were increasing in the age group of 40 - 50 years.

CONCLUSIONS
Cervical cancer is the most common malignancy in women in developing country like India. Pap test is a cheap, safe and practical diagnostic tool for early de-tection of cervical lesions in high risk group, so it should be established routine screening procedure. This study emphasized the importance of Pap smears for early detection of premalignant and malignant lesion of cervix and analysis of Cervical burden in remote areas of Bagalkot, India. The Colposcopy biopsy is also found to be helpful for detecting cervical lesions in high risk group.

REFERENCES
  1. Papanicolaou, GN, Traut, HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am Jr Obstet Gynecol 1941; 42:193-205.
  2. Bamanikar SA, Baravkar DS, Chandanwale SS etal. Study of cervical pap smear in a tertiary hospital. Indian Medical Gazette; 2014.
  3. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., and Parkin D.M. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.International Journal of Cancer December; 127 (12),2893–2917, 2010.
  4. D'Souza ND, Murthy NS, Aras RY. Projection of cancer incident cases for India-till 2026. Asian Pac J Cancer Prev.2013;14(7):4379-86.
  5. World Health Organization: WHO. Comprehensive cervical cancer control: a guide to essential practice; 2006.
  6. Ranbhat S, Dhungana G, Neupane M etal. Pap smear coverage and effect of knowledge and attitude regarding cervical cancer on utilization of the test by women in Udaipur district of Nepal: Journal of Chitwan Medical College 2014; 4(10): 31-35.
  7. Saraswathi KS, Aljabir F. Importance of Papanicolau (Pap) smear in Cervical Cancer screening intertiary care hospital: scholars research library 2012,4(5):1558-1559.
  8. Murioz N, Bosch FX, de Sanjosé S. The causal link between human papillomavirus and invasive cervical cancer: A population based case–control study. Int J Cancer. 2006;119:1108–24.
  9. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37 Suppl 8: S4–66.
  10. Patel M.M., Pandya A.N., Modi J. Cervical pap smear study and its utility in cancer screening, to specify the strategy for cervical cancer control. National Journal of Community Medicine; 2011, 2(1):49-51.
  11. Cioc AM, Julius CJ, Proca DM, Tranovich VL, Keyhani- Rofagha S. Cervical biopsy/cytology correlation data can be collected prospectively and shared clinically. Diagn Cytopathol. 2002;26(1):49–52.
  12. Mulligan NJ, de las Morenas A, Soto-Wright V, O’Brien MJ. Percentages of cervical cytologic diagnoses as a quality assurance method. Acta Cytol. 1998;42(4):928–32.
  13. BK Vaghela, VK Vaghela and PM Santwani. Analysis of abnormal cervical cytology in Papanicolaou smears at tertiary care center – A retrospective study: IJBAR (2014) 05 (01).
  14. Pragya Sharma, Manju Rahi, and Panna Lal. A Community-based Cervical Cancer Screening Program among Women of Delhi using Camp Approach: Indian J Community Med. 2010; 35(1): 86–88.
  15. Chankapa YD, Pal R, Tsering D. Correlates of cervical cancer screening among underserved women: Indian Journal of Cancer January–March 2011,48(1)40-46.
  16. M Bajpai, A Raina , S Dwivedi et al. A study of Pap smears in a tertiary care hospital: IOSR-JDMS, 15(2) Ver. II (Feb. 2016), pp: 93-95.

International Journal of Life-Sciences Scientific Research (IJLSSR) Open Access Policy Authors/Contributors are responsible for originality, contents, correct references, and ethical issues. IJLSSR publishes all articles under Creative Commons Attribution- Non-Commercial 4.0 International License (CC BY-NC).
https://creativecommons.org/licenses/by-nc/4.0/legalcode

How to cite this article:
Ali SS, Prabhu MH, Deoghare S, Inamdar SS, Deepak N: Spectrum of Cervical Lesions by Papanicolaou (Pap) Smear Screening in Remote Area of Bagalkot- A Camp Approach. Int. J. Life. Sci. Scienti. Res., 2017; 3(3): 986-991. DOI:10.21276/ijlssr.2017.3.3.4
Source of Financial Support:Nil, Conflict of interest: Nil